Taxanes and Breast Cancer‐Related Lymphedema
- 15 December 2024
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 131 (6) , 1000-1001
Abstract
Summary: No clear evidence‐based consensus has been reached on taxanes and the development of lymphedema. The cumulative effect of longer duration chemotherapy needs to be accounted for in analyses. Larger and more balanced study designs are needed to capture the risks of lymphedema from taxanes.Keywords
This publication has 13 references indexed in Scilit:
- The Association of Taxanes With Breast Cancer‐Related LymphedemaJournal of Surgical Oncology, 2024
- Investigation of the Association Between Breast Cancer-Related Lymphedema and the Side Effects of Taxane-Based Chemotherapy Using Indocyanine Green LymphographyLymphatic Research and Biology, 2022
- Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary DissectionJAMA Surgery, 2019
- Taxane-based chemotherapy and risk of breast cancer-related lymphedemaMedicine, 2019
- The Impact of Taxane-based Chemotherapy on the Lymphatic SystemAnnals of Plastic Surgery, 2019
- Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by TaxaneClinical Breast Cancer, 2018
- Adjuvant taxanes and the development of breast cancer-related arm lymphoedemaBritish Journal of Surgery, 2015
- Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohortBreast Cancer Research and Treatment, 2015
- Lymphedema Following Taxane-Based Chemotherapy in Women with Early Breast CancerLymphatic Research and Biology, 2014
- Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patientsBreast Cancer Research and Treatment, 2014